Venmax Drugs & Pharmaceuticals Limited has scheduled a meeting of its Board of Directors for Monday, August 31, 2026, at 4:30 pm. The gathering aims to finalize the company’s annual disclosures and governance updates for the financial year ending March 2026.

The agenda centers on the approval of the notice for the 37th Annual General Meeting (AGM), along with the Directors’ Report and the 37th Annual Report. The Board will also determine the date, time, and venue for the AGM, as well as fix cut-off dates for e-voting.

Governance and Compliance

In addition to annual reporting, the Board will consider the regularization of appointments for Additional Directors. This includes a change in designation for the Whole-time Director, subject to subsequent shareholder approval.

The meeting will also address logistical authorizations for the AGM, including the appointment of a Scrutinizer and an E-Voting Agency. These steps are taken pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Priyanka Agarwal, Company Secretary and Compliance Officer, issued the intimation on August 24, 2026.

Venmax Drugs & Pharmaceuticals Limited has filed its unaudited standalone financial results for the quarter ended June 30, 2026, with the Bombay Stock Exchange and the National Stock Exchange. The filing serves as a regulatory disclosure under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring transparency for investors regarding the company’s performance in Q1FY26.

The Board of Directors approved the financial results during a meeting held on Friday, August 7, 2026, in Hyderabad. The company has made the detailed financial statement, along with the Limited Review Report, accessible to stakeholders via its official website at www.venmaxdrugs.com . Investors can also access the documents by scanning the QR code provided in the exchange filing.

Regulatory Compliance

In accordance with Regulation 47 of the SEBI (LODR) Regulations, 2015, Venmax Drugs published newspaper advertisements containing the financial results on August 8, 2026. The advertisements appeared in “Financial Express” and “Nava Telangana.” This step ensures that the information reaches a broader audience, including retail investors who may not monitor digital channels exclusively.

Key Filing Details

The filing was signed by Venkata Rao Sadhanala, Managing Director, affirming the accuracy of the reported figures. The company’s registered office is located in Secunderabad, Telangana.